187 related articles for article (PubMed ID: 20619167)
1. [Post-translational modifications modulate estrogen receptor alpha activity in breast tumors].
Poulard C; Bouchekioua-Bouzaghou K; Sentis S; Corbo L; Le Romancer M
Med Sci (Paris); 2010; 26(6-7):636-40. PubMed ID: 20619167
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modifications of steroid receptors.
Faus H; Haendler B
Biomed Pharmacother; 2006 Nov; 60(9):520-8. PubMed ID: 16949786
[TBL] [Abstract][Full Text] [Related]
3. Cracking the estrogen receptor's posttranslational code in breast tumors.
Le Romancer M; Poulard C; Cohen P; Sentis S; Renoir JM; Corbo L
Endocr Rev; 2011 Oct; 32(5):597-622. PubMed ID: 21680538
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
[TBL] [Abstract][Full Text] [Related]
5. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain.
Tweedie-Cullen RY; Reck JM; Mansuy IM
J Proteome Res; 2009 Nov; 8(11):4966-82. PubMed ID: 19737024
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients.
Jiang J; Sarwar N; Peston D; Kulinskaya E; Shousha S; Coombes RC; Ali S
Clin Cancer Res; 2007 Oct; 13(19):5769-76. PubMed ID: 17908967
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and the estrogen receptor.
Leader JE; Wang C; Popov VM; Fu M; Pestell RG
Ann N Y Acad Sci; 2006 Nov; 1089():73-87. PubMed ID: 17261756
[TBL] [Abstract][Full Text] [Related]
10. Impact of post-translational modifications of proteins on the inflammatory process.
Ito K
Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260
[TBL] [Abstract][Full Text] [Related]
11. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM
J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304
[TBL] [Abstract][Full Text] [Related]
12. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
Dutertre M; Gratadou L; Dardenne E; Germann S; Samaan S; Lidereau R; Driouch K; de la Grange P; Auboeuf D
Cancer Res; 2010 May; 70(9):3760-70. PubMed ID: 20406972
[TBL] [Abstract][Full Text] [Related]
13. Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?
Welboren WJ; Sweep FC; Span PN; Stunnenberg HG
Endocr Relat Cancer; 2009 Dec; 16(4):1073-89. PubMed ID: 19628648
[TBL] [Abstract][Full Text] [Related]
14. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
15. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Lawrence J; MacMahon LP; Yue W; Berstein L
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):155-65. PubMed ID: 16024245
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic information and estrogen receptor alpha expression in breast cancer.
Giacinti L; Claudio PP; Lopez M; Giordano A
Oncologist; 2006 Jan; 11(1):1-8. PubMed ID: 16401708
[TBL] [Abstract][Full Text] [Related]
17. SUMO and estrogen receptors in breast cancer.
Karamouzis MV; Konstantinopoulos PA; Badra FA; Papavassiliou AG
Breast Cancer Res Treat; 2008 Jan; 107(2):195-210. PubMed ID: 17377839
[TBL] [Abstract][Full Text] [Related]
18. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
An W
Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.
Fortunati N; Bertino S; Costantino L; De Bortoli M; Compagnone A; Bandino A; Catalano MG; Boccuzzi G
Mol Cell Endocrinol; 2010 Jan; 314(1):17-22. PubMed ID: 19772891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
